InterCure Ltd. (NASDAQ:INCR – Get Free Report) shares dropped 0.7% during mid-day trading on Wednesday . The stock traded as low as $1.61 and last traded at $1.61. Approximately 24,045 shares traded hands during trading, an increase of 31% from the average daily volume of 18,333 shares. The stock had previously closed at $1.62.
InterCure Stock Performance
The company has a debt-to-equity ratio of 0.15, a current ratio of 1.78 and a quick ratio of 1.15. The stock has a 50 day simple moving average of $1.63 and a 200 day simple moving average of $1.71.
Institutional Investors Weigh In On InterCure
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in INCR. Moore Capital Management LP purchased a new position in shares of InterCure in the fourth quarter valued at about $156,000. Jane Street Group LLC bought a new stake in shares of InterCure in the third quarter worth about $49,000. Finally, Virtu Financial LLC purchased a new position in InterCure during the 3rd quarter valued at about $43,000. 8.34% of the stock is currently owned by institutional investors.
InterCure Company Profile
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Read More
- Five stocks we like better than InterCure
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Bank Stocks – Best Bank Stocks to Invest In
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.